Related by context. Frequent words. (Click for all words.) 70 pharmacodynamic effects 68 pharmacokinetic profiles 67 pharmacokinetic profile 66 tolerability profile 66 pharmacodynamics 65 CCX# 65 Neuradiab 65 Sym# 65 Azedra 65 decitabine 64 pharmacokinetic properties 64 biodistribution 64 pharmacokinetic studies 64 rHuPH# 64 oral bioavailability 64 serum concentrations 64 pharmacodynamic 64 active comparator 63 AZX# 63 Pharmacokinetic 63 goserelin 63 xenograft models 63 #mg dose [001] 63 MIRCERA 63 tipranavir 63 BNC# 62 mcg dose 62 placebo controlled trials 62 administered subcutaneously 62 omecamtiv mecarbil 62 dosing regimens 62 TRIOLEX 62 Chrysalin 62 pharmacokinetic 62 tolvaptan 62 mg kg dose 62 intravenously administered 62 placebo controlled studies 62 PREZISTA r 61 Amrubicin 61 achieved statistical significance 61 pharmacokinetics 61 adalimumab 61 eszopiclone 61 nab paclitaxel 61 LY# [003] 61 CA4P 61 #ME# 61 platelet inhibition 61 tanespimycin 61 aclidinium 61 efficacy 61 dose limiting toxicities 61 cardiac toxicity 61 noninferiority 61 elotuzumab 61 chlorambucil 61 dose cohorts 61 interferon alfa 61 teduglutide 61 ascending doses 61 PROMACTA 61 serum calcium 61 C1 INH 61 randomized controlled clinical trials 61 NOXAFIL 61 Secondary endpoints 61 pertuzumab 61 DAVANAT 61 virologic response 61 tolerability 61 iSONEP 61 degarelix 60 fondaparinux 60 therapeutic regimens 60 mycophenolate mofetil 60 SRT# [003] 60 irbesartan 60 events SAEs 60 glucose lowering 60 Cmax 60 glargine 60 X Excite 60 talabostat 60 azacitidine 60 immunogenicity 60 placebo controlled clinical 60 PRX# 60 neuroprotective effects 60 radiolabeled 60 vitro experiments 60 Estradiol 60 pramlintide 60 PS# [001] 60 RRMS patients 59 placebo controlled clinical trials 59 MAP# 59 APOPTONE 59 LY# [002] 59 secondary efficacy endpoints 59 eniluracil